<DOC>
	<DOCNO>NCT01311557</DOCNO>
	<brief_summary>The purpose study Td519 demonstrate Adacel® vaccine ( Tetanus Toxoid , Reduced Diphtheria Toxoid Acellular Pertussis Adsorbed ) safe immunogenic person 10 year age . Primary Objectives : - To compare pertussis antibody response induce Adacel® person 10 &lt; 11 year age induce Adacel person 11 &lt; 12 year age . - To compare booster response pertussis antigen induce Adacel person 10 &lt; 11 year age induce Adacel person 11 &lt; 12 year age . - To compare booster response tetanus diphtheria induce Adacel person 10 &lt; 11 year age induce Adacel person 11 &lt; 12 year age . Secondary Objective : - To compare seroprotection rate tetanus diphtheria induce Adacel person 10 &lt; 11 year age induce Adacel person 11 &lt; 12 year age .</brief_summary>
	<brief_title>Study Adacel® Vaccine Administered Persons 10 Years Age</brief_title>
	<detailed_description>Study participant receive single dose study vaccine monitor safety day vaccination 30 day post-vaccination .</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Age &gt; 10 &lt; 12 year age time vaccination . Assent form sign dated subject , informed consent sign dated parent ( ) another legally acceptable representative ( independent witness require local regulation ) . Subject parent/guardian able attend schedule visit comply trial procedure . For female childbearing potential , abstinence use effective method contraception least 4 week prior vaccination least 4 week vaccination . Documented vaccination history receive 5 previous dos DTaP ( combination diphtheria , tetanus , acellular pertussis ) vaccine ( consist 3 infant dos first year life , 4th dose 2nd year life , 5th dose 4 6 year age ) . Any condition , opinion Investigator , would pose health risk participant interfere evaluation vaccine . Serious , acute , chronic disease unstable , opinion Investigator , might : ( ) interfere ability participate fully study ; ( ii ) interfere evaluation vaccine . Known suspected congenital acquire immunodeficiency ; receipt immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month ; longterm systemic corticosteroid therapy ( prednisone equivalent 2 consecutive week within past 3 month ) . Prior receipt pertussis , diphtheria , tetanus contain vaccine within past 5 year . A personal history physiciandiagnosed laboratory confirm pertussis disease within last 2 year . A previous severe reaction pertussis , diphtheria tetanus vaccine include immediate anaphylaxis , encephalopathy within 7 day seizure within 3 day receive vaccine . Receipt blood bloodderived product past 3 month , might interfere assessment immune response . History allergy egg protein , latex , constituent vaccine . Suspected known hypersensitivity vaccine component , history lifethreatening reaction vaccine use trial vaccine contain substance . Receipt vaccine within 30 day receive study vaccine , plan receive another vaccine 2nd visit ; except influenza vaccine may receive 30 15 day ( less 15 day ) receive study vaccine . Participation another interventional clinical trial investigate vaccine , drug , medical device , medical procedure 30 day precede first study vaccination course study . Seropositivity Human Immunodeficiency Virus ( HIV ) , Hepatitis B , Hepatitis C , report parent/guardian . Laboratoryconfirmed thrombocytopenia , bleed disorder , receipt anticoagulant 3 week precede inclusion , contraindicate intramuscular vaccination , discretion Investigator . Known pregnancy , positive urine serum pregnancy test . Prior personal history GuillainBarré syndrome . Identified investigator employee investigator study center direct involvement propose study , identify immediate family member ( i.e. , parent , spouse , natural adopt child ) investigator employee direct involvement propose study .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Tetanus</keyword>
	<keyword>Diphtheria</keyword>
	<keyword>Pertussis</keyword>
	<keyword>Tdap vaccine</keyword>
	<keyword>Adacel®</keyword>
</DOC>